logo

For the Inventor, By the Inventor

Wahlitz, Germany

Gerhard Fries

This inventor holds 6 USPTO granted patents. Top assignees: Esparma Gmbh, Imtm Gmbh, Serumwerk Bernburg Ag. Active years: 2002-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Fries. Retrieved from https://idiyas.com/inventor/gerhard-fries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Osterweddingen, DE (2002 - 2004)
  • Wahlitz, DE (2003 - 2009)

Company Filing History:

goldMedal4 out of 4 
 
Esparma Gmbh
 patents
silverMedal1 out of 7 
 
Imtm Gmbh
 patents
bronzeMedal1 out of 2 
 
Serumwerk Bernburg Ag
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2009

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7531567 - Use of a medicament containing an effector of the glutathione metabolism together with α-lipoic acid in kidney replacement therapy (2009-05-12),
2. 7429614 - Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus (2008-09-30),
3. 6719986 - Hyaluronate lyase used for promoting penetration in topical agents (2004-04-13),
4. 6689349 - Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis (2004-02-10),
5. 6518300 - Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or its physiologically compatible salts (2003-02-11),
6. 6413950 - Pharmaceutical preparation containing dithranol (2002-07-02),

Title: Gerhard Fries: Innovator in Medicinal Chemistry

Introduction

Gerhard Fries is a notable inventor based in Wahlitz, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the area of kidney replacement therapy and diabetes treatment. With a total of 6 patents to his name, Fries has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Fries' latest patents include groundbreaking inventions that focus on the use of a medicament containing an effector of the glutathione metabolism together with α-lipoic acid in kidney replacement therapy. This invention addresses the treatment of disturbances in cellular thiol status and related disorders. Another significant patent involves a medicament for treating diabetes mellitus, which combines an effector of the glutathione metabolism with α-lipoic acid. This formulation allows for the simultaneous or graduated treatment of thiol-disulfide status disturbances that occur in diabetes.

Career Highlights

Throughout his career, Gerhard Fries has worked with various companies, including Esparma GmbH. His work has been pivotal in developing new therapeutic approaches that enhance patient care and treatment outcomes.

Collaborations

Fries has collaborated with notable professionals in his field, including Dieter Koegst and Wolfgang A Wohlrab. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Gerhard Fries is a distinguished inventor whose work in medicinal chemistry has led to innovative solutions for kidney replacement therapy and diabetes treatment. His contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…